NextCure, Inc. (NXTC) — Financial statements
Income statement, balance sheet, and cash flow for NextCure, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 2 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | -2 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 45↑8.3% | 41↓13.4% | 48↓11.6% | 54↑8.0% | 50 | |
| General & Administrative Expenses | 13↓19.2% | 16↓20.2% | 20↓9.2% | 22↑5.5% | 21 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 13↓19.2% | 16↓20.2% | 20↓9.2% | 22↑5.5% | 21 | |
| Other Expenses | -2↓186.0% | 3 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 55↓7.2% | 60↓11.7% | 68↓10.9% | 76↑7.3% | 71 | |
| Total Costs & Expenses | 58↓3.6% | 60↓11.7% | 68↓10.9% | 76↑7.3% | 71 | |
| Operating Results | ||||||
| Operating Income | -58↑3.6% | -60↑11.7% | -68↑10.9% | -76↓7.3% | -71 | |
| Depreciation & Amortization | 2↓23.7% | 3↓22.2% | 4↓10.7% | 4↓1.3% | 4 | |
| EBITDA | -55↓2.0% | -54↑15.0% | -64↑10.9% | -72↓7.8% | -67 | |
| EBIT | -58↓0.7% | -57↑15.4% | -68↑10.9% | -76↓7.3% | -71 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00 | 0.00 | 0.00↓100.0% | 1↑1642.0% | -0.08 | |
| Interest Income | 0.00 | 0.00 | 0.00↓100.0% | 1↑88376.1% | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.08 | |
| Non-Operating Income | 0.00↑100.0% | -3 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 2↓56.7% | 4↓16.7% | 5↑317.9% | 1↓14.5% | 1 | |
| Income Before Tax | -56↓0.3% | -56↑11.3% | -63↑16.1% | -75↓7.7% | -69 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -56↓0.3% | -56↑11.3% | -63↑16.1% | -75↓7.7% | -69 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -56↓0.3% | -56↑11.3% | -63↑16.1% | -75↓7.7% | -69 | |
| Bottom-Line Net Income | -56↓0.3% | -56↑11.3% | -63↑16.1% | -75↓7.7% | -69 | |
| EPS (Basic) | -19.65↑17.7% | -23.88↑11.7% | -27.04↑16.3% | -32.32↓7.2% | -30.15 | |
| EPS (Diluted) | -19.65↑17.7% | -23.88↑11.7% | -27.04↑16.3% | -32.32↓7.2% | -30.15 | |
| Weighted Average Shares | 3↑22.0% | 2↑0.5% | 2↑0.3% | 2↑0.5% | 2 | |
| Weighted Average Diluted Shares | 3↑22.0% | 2↑0.5% | 2↑0.3% | 2↑0.5% | 2 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.